Tharimmune announced a $540 million private sale, led by DRW and others, to establish the Canton Coin treasury.

On November 3, Tharimmune, Inc. (NASDAQ: THAR) today announced that it has entered into private sale subscription agreements with several institutional investors and accredited investors (“this issuance”), intending to sell common stock (or equivalent prepaid warrants) at a price of $3.075 per share, with an expected total issuance amount of approximately $540 million (before underwriting fees and other issuance expenses). This issuance is led by DRW and Liberty City Ventures, with notable participating investors including: ARK Invest, Bitwave, Broadridge, Clear Street, Copper, Digital Asset, Feynman Point Asset Management, Five North, Kaiko, Kenetic, CEX, LendOS, Lukka, Nima Capital, MPCH, Obsidian Software, Polychain Capital, Proof Group, SBI Group, The Tie, Tradeweb Markets, and 7RIDGE. The regulatory body managing the Canton Network, Canton Foundation, also participated in this private sale. Tharimmune is the first and only publicly traded company supported by Canton Foundation. This issuance is expected to be completed around November 6, 2025, subject to customary delivery conditions. The company plans to use the net proceeds from the private sale to acquire Canton Coin (CC) — a utility token that supports interoperability and settlement of the Canton Network, and for working capital and general corporate purposes. The company also plans to operate on the Canton Network as a Super Validator and run additional validator nodes to acquire more CC tokens.